Two Botulinum Toxin A Injections in Patients With Chronic Orofacial Myalgia: A Randomised, Double‐Blind, Controlled Multicenter Trial With Nine‐Month Follow‐Up
Journal of Oral Rehabilitation · 2025
DOI: 10.1111/joor.70032 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Oral Rehabilitation, 2025. Verfasst von Christine Lennartsson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Orofacial Pain, Mölndal, Public Dental Service, Region Västra Götaland, Sweden. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Facial Pain, Neuromuscular Agents, Myalgia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Sahlgrenska Akademin, Västra Götalandsregionen.
Abstract (Originalsprache)
Background
Conventional treatment for reducing pain is not always successful in patients with chronic orofacial myalgia.
Objective
The objective of this study was to investigate the pain‐reducing efficacy of two botulinum toxin A injections in patients with chronic orofacial myalgia who had already received conservative treatment.
Methods
The patients included were 18 years or older and diagnosed with myalgia according to the Diagnostic Criteria for Temporomandibular Disorders. Their pain had persisted for more than six months in spite of previous conservative treatment. The design was a randomised, double‐blind, placebo‐controlled, multicenter, parallel group study. Participants received two injections of botulinum toxin A or saline at an interval of three months. Follow‐up visits were conducted at one, three, four, six and nine months after the first injection.
Results
Seventy‐two patients were enrolled and sixty‐nine completed the study. Between baseline and all follow‐up visits, there was a significant decrease in VAS pain intensity for both groups, but the difference between groups was not significant.
Conclusion
The use of botulinum toxin A in managing chronic orofacial myalgia did not offer any additional pain relief compared with saline at any of the follow‐up occasions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinic of Orofacial Pain, Mölndal, Public Dental Service, Region Västra Götaland, Sweden.
- Department of Orofacial Pain, Institute of Odontology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Clinic of Orofacial Pain, Gothenburg, Public Dental Service, Region Västra Götaland, Sweden.
- Department of Oral and Maxillofacial Surgery, Institute of Odontology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Clinic of Oral and Maxillofacial Surgery, Borås, Public Dental Service, Region Västra Götaland, Sweden.
- Department of Orofacial Pain and Jaw Function, Faculty of Odontology, Malmö University, Malmö, Sweden.
ORCID-Profile: Christine Lennartsson, Ellie Saghafi, Behnosh Öhrnell Malekzadeh, Per Alstergren, Birgitta Johansson Cahlin
Förderung
- Sahlgrenska Akademin
- Västra Götalandsregionen
Zitieren
APA
Lennartsson, C., Saghafi, E., Malekzadeh, B. Ö., Alstergren, P., & Cahlin, B. J. (2025). Two Botulinum Toxin A Injections in Patients With Chronic Orofacial Myalgia: A Randomised, Double‐Blind, Controlled Multicenter Trial With Nine‐Month Follow‐Up. Journal of Oral Rehabilitation. https://doi.org/10.1111/joor.70032
Vancouver
Lennartsson C, Saghafi E, Malekzadeh BÖ, Alstergren P, Cahlin BJ. Two Botulinum Toxin A Injections in Patients With Chronic Orofacial Myalgia: A Randomised, Double‐Blind, Controlled Multicenter Trial With Nine‐Month Follow‐Up. Journal of Oral Rehabilitation. 2025. doi:10.1111/joor.70032
BibTeX
@article{Lennartsson2025,
author = {Lennartsson, Christine and Saghafi, Ellie and Malekzadeh, Behnosh Öhrnell and Alstergren, Per and Cahlin, Birgitta Johansson},
title = {Two Botulinum Toxin A Injections in Patients With Chronic Orofacial Myalgia: A Randomised, Double‐Blind, Controlled Multicenter Trial With Nine‐Month Follow‐Up},
journal = {Journal of Oral Rehabilitation},
year = {2025},
doi = {10.1111/joor.70032}
}
EUVIMED